Tag: New York Valves 2026
Registry data offer real-world comparison of Triclip against randomised trial performance
Early registry data shared at the 2026 New York Valves meeting (24–26 June, New York, USA) demon...
Registry data hint at promise for TMVR system in MAC
Patients with mitral valve dysfunction coupled with mitral annular calcification (MAC) who were ...
TAVI holds up to SAVR at seven years on durability in PARTNER 3 trial
Long-term follow-up data from the PARTNER 3 trial, a major randomised trial of management of sev...
Favourable outcomes at one-year with TAVI device for aortic regurgitation
Favourable outcomes were seen at one year among patients with symptomatic severe aortic regurgit...
